PHD Access has secured €37.7 million to expand its specialist access business across Europe, positioning the Irish-rooted group to pursue acquisitions and growth in life sciences, semiconductor manufacturing and data centres. The investment gives the family-owned company capital to consolidate its existing markets and enter new territories as demand for complex industrial infrastructure continues to create opportunities for specialist contractors.

MML Ireland is investing €26 million, with Goodbody Capital Partners contributing €11.7 million on behalf of AIB. The funding will support expansion and acquisitions, according to Dealroom. The transaction remains subject to regulatory approval.

PHD provides scaffolding and specialist access services for construction, maintenance and industrial projects. Its work spans life sciences, semiconductor manufacturing, data centres, infrastructure and heritage sites, placing the group within the supply chain supporting complex production environments. The company operates across Ireland, the UK, Denmark, Germany, Spain and Portugal, and employs more than 600 people. MML Ireland expects the group to generate approximately €90 million in pro forma revenue during the current financial year.

For pharmaceutical and biotechnology operators, the investment highlights the infrastructure expertise required to build, maintain and adapt specialised facilities. Scaffolding and engineered access can support installation work, equipment maintenance and refurbishment where restricted spaces, technical systems and operational requirements demand carefully planned access. PHD’s expansion could extend its reach across European life sciences markets, although the investment announcement does not identify new pharmaceutical contracts or guarantee additional work in the sector.

The next phase is geographic expansion. PHD plans to enter the Netherlands, Sweden and Finland during 2026 while pursuing acquisitions of established access businesses. The Dwyer family will retain majority ownership and continue leading the company, with Danny Dwyer remaining chief executive and Sean Dwyer chief strategy officer. The strategy combines external investment with continuity in family leadership, giving the group a platform to pursue its stated ambition of becoming Europe’s leading specialist access provider. A&L Goodbody’s deal announcement provides further confirmation of the transaction.

For life sciences procurement and facilities teams, a larger specialist provider could offer another option as projects and maintenance requirements extend across multiple markets. The commercial impact will depend on PHD’s ability to complete acquisitions, establish new operations and convert expansion into reliable service capacity.

For the sector, the lesson is direct: growth capital can accelerate the consolidation of specialist infrastructure services, giving an Irish-rooted provider the means to pursue a larger European role in the supply chain supporting life sciences and advanced manufacturing.

Source: Dealroom / MML Ireland / A&L Goodbody